Chronotherapeutic optimization of radioactive iodine therapy in differentiated thyroid cancer: The rationale for evening administration

doi:10.5493/wjem.v15.i4.110893

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=0

Dec 20, 2025 (publication date) through Dec 19, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Exp Med. Dec 20, 2025; 15(4): 110893
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.110893

Open in New Tab Full Size Figure Download Figure

Figure 1 Thyrotropin (thyroid-stimulating hormone) fluctuations in normal and hypothyroid states. Shaded areas denote time windows for radioactive iodine-131 therapy (Radioactive iodine Rx). TSH: Thyroid-stimulating hormone; RAI: Radioactive iodine.

Citation: Meristoudis G, Savvidis C, Ilias I. Chronotherapeutic optimization of radioactive iodine therapy in differentiated thyroid cancer: The rationale for evening administration. World J Exp Med 2025; 15(4): 110893
URL: https://www.wjgnet.com/2220-315x/full/v15/i4/110893.htm
DOI: https://dx.doi.org/10.5493/wjem.v15.i4.110893